글로벌 게놈 시장 – 2030년까지의 산업 동향 및 예측

게놈 시장 분석 및 규모

2023-2030년 예측 기간 동안 글로벌 유전체학 시장 성장에 기여하는 필수 요인에는 유전체학 응용 프로그램 증가, 정부 지원 증가, 유전체학 연구 수 증가, 시퀀싱 비용 감소가 포함됩니다. 유전체학 시장은 최신 유전적 발전과 다중 유전성, 유전체 내 현상, 유전적 상호작용, 이종 유전 등과 같은 다양한 연구 분야에서의 응용으로 인해 성장 단계에 있습니다. 이와 함께 생명공학 및 합성 생물학 응용 ​​프로그램은 2023년에서 2030년 예측 기간 동안 유전체학 시장 성장을 증가시킬 것으로 예상됩니다.

Data Bridge Market Research는 2022년에 315.6억 달러였던 유전체학 시장이 2030년까지 1,061.4억 달러에 도달할 것으로 예상하며, 2023년에서 2030년까지의 예측 기간 동안 16.37%의 CAGR로 성장할 것으로 분석했습니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

게놈 시장 범위 및 세분화

시장 정의

유전체학은 DNA 코드를 해독, 해석, 적용, 해석하여 다양한 문제에 적용하는 연구입니다. 유전체학은 오늘날 세계에서 가장 유용한 기술 중 하나입니다. 유전체학은 게놈 시퀀싱 에 중요한데 , 유전체학을 통해 다양한 일반 변이를 식별할 수 있기 때문에 무증상자에게는 질병 발병 위험이 더 높을 수 있습니다. 유전체학은 다양한 미발견 항균 화합물을 식별하고 박테리아성 질병을 멀리하는 데 도움이 됩니다.

게놈 시장 역학

운전자

• 암 발병률 증가

암의 발생률과 암 연구에서 차세대 시퀀싱의 적용 증가는 시장 성장에 도움이 되는 중요한 요인입니다. 유전체학은 암을 진단하고 치료하는 방식을 바꾸고 있습니다. 유전체 연구는 혈액 샘플을 사용하여 암을 진단하는 방법을 개선하고 있습니다. 유전된 암을 찾기 위한 선별 검사는 유전체학으로 인해 증가하고 있습니다. 따라서 암 발생률 증가와 암을 진단하고 치료하기 위한 유전체학의 성공적인 사용은 시장 성장을 촉진하고 있습니다.

• 인공지능의 구현

지난 몇 년 동안 유전체학에서 인공지능(AI) 구현이 증가했습니다. 시퀀싱 기술을 통해 생성된 데이터는 인공지능 알고리즘에 의해 분석되어 특정 질병의 원인이 되는 유전적 변이를 빠르고 정확하게 진단할 수 있습니다. 인공지능은 또한 개인화된 환자 치료 계획을 개발하는 데 사용됩니다. 이를 통해 의사는 환자에게 가장 유익한 치료를 처방할 수 있습니다. 따라서 인공지능을 사용하면 정확한 결과가 제공되므로 AI는 시장 성장의 주요 기회가 되고 있습니다.  

기회

• Research and development on genomics

The growing focus on genomics research and developments is contributing to the growth of the genomics market. In July 2022, WHO's Science Council of Experts was launched for the equitable expansion of genomics. It includes a focus on increasing access to genomic technologies, majorly in countries with low and middle incomes, by directing the shortfalls in the financing, materials, highly trained professionals, and laboratory infrastructure. Therefore, all these initiatives are expected to help in the significant growth of the market.

• Applications of genomics in rare disorder diagnosis

Through large-scale genetic testing, it is possible to increase diagnosis and treatment options for patients with rare diseases. The ability to understand genomes quickly and inexpensively has led to advances in the diagnosis of rare disorders. This increased diagnosis and treatment provide significant relief to patients suffering from rare disorders, as well as help the patients to understand the risk of disorder to future generations. Thus, applications of genomics in diagnosing and treating rare disorders would help grow the market.

Restraints/Challenges

• Requirement of trained professionals

Genomics involve complex procedures such as a combination of recombinant DNA technology, DNA sequencing methods, and bioinformatics. It is used to sequence, assemble, and analyze the structure and function of genomes. Thus, it requires skilled genetics professionals. The lack of skilled genetics professionals is a major challenge hindering market growth. The shortage of trained genetic professionals has resulted in wrong result interpretations and false observations during genetic research and testing. Therefore, the lack of trained professionals is one of the main challenges hindering the global market.

•  Handling of sensitive instruments

Genomics studies involve procedures such as gene editing, amplification, sequencing, and multiplexing, which are highly complex and sensitive. Advanced instruments such as microarray equipment, PCR instruments, centrifuges, analyzers, liquid handling equipment, and sequencers are used in these procedures. Therefore, all the instruments must be handled with the utmost care. Handling these sensitive instruments is a major growth obstructing factor for the market.

This genomics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the genomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

• In March 2021, PCR Biosystems launched a range of IsoFast Bst Polymerase reagents for rapid, robust, and sensitive DNA and RNA amplification, enabling faster results and facilitating DNA and RNA amplification in the field without specialized thermos-cycling equipment. Therefore, the factors such as new product launches and the rising usage of consumables in genomics will help boost the market's growth.
• In August 2022, Trivitron Healthcare launched the Centre of Excellence with state-of-the-art R&D and manufacturing facilities in India. This center will implement research and innovation in the field of genomics and others. This would significantly help the market's growth in the Asia Pacific Region.
• In Feb, 2023, Complete Genomics, announced the launch of DNBSEQ-T20, a genetic sequencer calming it would generate the first sub-$100 with low to midrange throughput.
• In July 2020, Illumina launched TruSight software suite, which supplies readymade infrastructure to recognize the potentiality of whole-genome sequencing of old diseases.

Global Genomics Market Scope

The genomics market is segmented on the basis of deliverables, technology, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Deliverables

• Products
• Instruments
• Consumables & Reagents
• Software and Services
• NGS-based Services
• Core Genomics Services
• Biomarker Translation Services
• Computational Services
• Others

Technology

• Sequencing
• Next Generation Sequencing
• DNA Sequencing
• Bisulfide Sequencing
• Microarray
• Polymerase Chain Reaction (PCR)
• Nucleic Acid Extraction
• Purification
• Others

Process

• Library Preparation
• Data Analysis
• Imaging

Application

• Functional Genomics
• Transfection
• Ribonucleic acid (RNA) Interference
• Mutational Analysis
• Single nucleotide polymorphisms (SNP) Analysis
• Epigenomics
• Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
• Methylated DNA Immunoprecipitation (MeDIP)
• High-Resolution Melt (HRM)
• Chromatin Accessibility Assays
• Pathway Analysis
• Bead-Based Analysis
• Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
• Biomarker Discovery
• Mass Spectrometry
• Statistical Analysis
• Bioinformatics
• Others

End-User

• Government

• Healthcare facilities
• Hospitals and Clinics
• Diagnostics Centers,
• Academic Institutes
• Clinical Research
• Biotechnology
• Pharmaceutical Companies
• Others

Genomics Market Regional Analysis/Insights

The genomics market is analysed and market size insights and trends are provided by deliverables, technology, process, application and end-user as referenced above.

The countries covered in the genomics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the genomics market because of the rapid growth of sequencing technology U.S.’s genomics research grants and funds, help from major industrial players and increasing cases of cancer within the region. All these factors are further anticipated to boost market’s growth in North American Region.   

Asia Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 because of the increased demand for genomics applications in diagnostics and the growing demand for novel therapeutic drugs for fighting against the increased incidence of diseases in the region. Several major human genome sequencing projects are being performed in the region, significantly contributing to the growth of the market in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Genomics Market Share Analysis

The genomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to genomics market.

유전체학 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Agilent Technologies, Inc. (미국)
• Bio-Rad Laboratories, Inc. (미국)
• BGI(중국)
• 컬러 헬스(Color Health, Inc.) (미국)
• 다나허(미국)
• 에펜도르프 SE(독일)
• Eurofins Scientific(룩셈부르크)
• F. 호프만-라 로슈 유한회사(스위스)
• GE 헬스케어(미국)
• 일루미나 주식회사(미국)
• Myriad Genetics, Inc. (미국)
• Oxford Nanopore Technologies plc. (영국)
• 팩바이오(미국)
• QIAGEN(독일)
• Diagnostics Incorporated (미국)
• Thermo Fisher Scientific, Inc. (미국)
• 23andMe, Inc. (미국)
• 파운데이션 메디신 주식회사(미국)
• IntegraGen(프랑스)
• Genome Diagnostics Pvt. Ltd. (인도)
• 사이티바(미국) 

SKU-14489